Thanks for the shout out brother.
The truth is that we we're early to IHL's story when others weren't looking at the big picture around 1-2c. IHL was moving into cannabis sector and people wrote the company off since it was selling mouthguards at the time (we had friends that just couldn't overlook that fact). In fact, when IHL announced its initial four back-to-back cannabis trials the market didn't give a rats about the news and the share price still traded around the 2-3c range for ages. We wrote a lot of updates around this share price talking about how IHL will become the next billion dollar behemoth/ ResMed!
The market did nothing but ignore the company's progress for ages...
It's amazing how many people want to get rich in 1-2 weeks/months...and ignore what could happen in 2-3 years.
Mind you, 2-3 years isn't a long time at all!
In fact, GW Pharmaceuticals' drug development program took 3.5 years to complete. When it listed on the NASDAQ it was capped at around US$100M on the LSE (UK) and then got taken over by Jazz Pharmaceuticals for US$7.2B 3.5 years later.
GW Pharmaceuticals -- like IHL is on the ASX -- was largely ignored when it was listed on the London Stock Exchange.
It took GW Pharmaceuticals to move to the NASDAQ to get noticed by the big money.
Right now, IHL looks like its where GW Pharmaceuticals was 2-3 years ago. Indeed, with some little success, IHL's share price could be worth $2-3++ in 2-3 years. That's why we haven't updated our blog since January. With the extensive nature of our January blog post, which discussed the scientific background of the trials/ probability of success (excluding TBI), we thought it would be best for newcomers to read the amount of research that backs up IHL's clinical trials and why they should all be a raging success.
We mainly comment on twitter these days, as most people in here know, and try to add value on HC when possible. But there's a lot of good posters on this forum who have kept people in the know - especially @andres who writes consistently informative weekly posts.
Hats off to him/her.
If there's another opportunity that comes up, we'll definitely provide a write-up on on our blog to our 1000+ readers. For now, we're happy doing nothing and watch IHL's share price go higher and higher. As you correctly pointed out, we just hit the $1 million dollar mark with our blog portfolio at 38 cents (we didn't do the calcs, but knew we were close)! So we'll probably do a short update discussing IHL's outlook on the blog to celebrate soon (roughly 1k words or less).
To your first million,
-Trading For Millions